Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Promising therapy for dissociative disorders put to the test

NCT ID NCT06917209

Symptom relief Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests a type of talk therapy called dissociation-focused cognitive behavioral therapy (DF-CBT) for people with dissociative disorders, such as depersonalization or dissociative identity disorder. The goal is to see if it reduces symptoms like feeling detached from yourself or your memories. The study will involve 140 adults and compare DF-CBT to usual care over 3 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

May 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥ 18 years * Membership of a social security scheme * Participant's express consent * Have at least one diagnosis of dissociative disorder among the following: depersonalization/derealization disorder, dissociative identity disorder, unspecified dissociative disorder. * Be able to carry out psychotherapy sessions. * If taking psychiatric medication, treatment must have been stable for at least 30 days. Exclusion Criteria: * Present one of the following current diagnoses: substance use disorder (excluding tobacco), neurodevelopmental disorder, anorexia nervosa, severe depressive disorder, schizophrenia spectrum disorder, bipolar disorder, personality disorder other than borderline personality disorder. * Present cognitive deficits. * Be engaged in psychotherapeutic work. * Be undergoing benzodiazepine treatment. * Pregnant women and breastfeeding women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depersonalization/derealization disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

depersonalization disorder dissociative disorder multiple personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dissociative disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Régional du Psychotraumatisme CRP / CHRU TOURS

    RECRUITING

    Tours, France

  • Centre Régional du Psychotraumatisme du Grand Est / CHU STRASBOURG

    NOT_YET_RECRUITING

    Strasbourg, France

  • Centre départemental de Psychotraumatologie (unité TCC) / ORLEANS

    NOT_YET_RECRUITING

    Orléans, France

  • Centre régional du Psychotraumatisme des Hauts de France / CHU LILLE

    NOT_YET_RECRUITING

    Lille, France

  • Psychiatrie / CHU ANGERS

    NOT_YET_RECRUITING

    Angers, France

  • Unité de Neuromodulation / CHU de Tours

    RECRUITING

    Tours, France

  • Unité de neuromodulation en psychiatrie / CHU NANTES

    NOT_YET_RECRUITING

    Nantes, France

  • Urgences psychiatrique / CHU MONTPELLIER

    NOT_YET_RECRUITING

    Montpellier, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.